Orthofix Medical Inc.

NASDAQ:OFIX

Medical - Devices

Healthcare
$6.61 +0.33%

+$0.03 today

Market cap
$269.42M
Beta
0.71
P/E (TTM)
-6.2
EPS (TTM)
-$1.48
52W Low $9.12High $16.99

Volume 0.40M

Average 0.38M

OFIX EBITDA Margin

EBITDA as a percentage of revenue.

Orthofix Medical Inc.NASDAQ: OFIX

EBITDA Margin · Q1 FY2026 · quarter ended Mar 2026

EBITDA Margin widens to -0.9%

EBITDA Margin was -0.9% in Q1 FY2026, up 5.3 pp from a year earlier. On a trailing-twelve-month basis it was 11.5%, up 13.4 pp year over year. Over 3 fiscal years it narrowed by 6.1 pp.

Context

  • EBITDA Margin widened in 2 of the last 3 fiscal years.

What to watch

Whether EBITDA Margin reaches the consensus estimate from 3 analysts of 6.0% for the fiscal year ending Dec 2026, up from -2.7% in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
-0.9%-42.5 pp QoQ
Last fiscal yearDec 2025
-2.7%+1.6 pp YoY
LTMMar 2026
11.5%+13.4 pp YoY
EBITDA Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+5.3 pp-3.1 pp-8.4 pp
1 year+1.6 pp+8.7 pp+7.1 pp
3 years-6.1 pp+9.1 pp+15.2 pp
5 years——
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EBITDA Margin history

Percent of revenue · from the income statement

Latest · FY2025
-2.7%
Year-over-year change
+1.6pp
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EBITDA Margin vs competitors

How OFIX compares with its peers on the latest reported figures

  • OFIX's LTM Mar 2026 EBITDA Margin of 11.5% is the highest of the 10 companies compared; the peer median is -64.8%.
  • Its year-over-year change of +13.4 pp is the 4th highest of 10, against a peer median of -2.6 pp.
  • Over three fiscal years its change of -6.1 pp compares with a peer median of +46.2 pp.
OFIX Competitors Peer median
EBITDA Margin for OFIX and competitors
Company Period LTM level YoY 3-year change
OFIXOrthofix Medical Inc.LTM Mar 202611.5% +13.4 pp-6.1 pp
ESPREsperion Therapeutics, Inc.LTM Mar 20269.5% +43.6 pp+249.5 pp
VREXVarex Imaging CorporationLTM Apr 2026-0.7% -9.9 pp-12.9 pp
SIBNSI-BONE, Inc.LTM Mar 2026-2.9% +7.7 pp+46.2 pp
AVNSAvanos Medical, Inc.LTM Mar 2026-3.0% +46.3 pp-16.1 pp
BFLYButterfly Network, Inc.LTM Mar 2026-64.8% -2.6 pp+152.7 pp
PACBPacific Biosciences of California, Inc.LTM Mar 2026-66.6% +85.7 pp+198.6 pp
LABStandard BioTools Inc.LTM Mar 2026-94.5% -30.2 pp+72.1 pp
DRIODarioHealth Corp.LTM Mar 2026-151.9% -4.9 pp+45.9 pp
ABSIAbsci CorporationLTM Mar 2026-5818.9% -3878.5 pp-2094.8 pp
MLTXMoonLake ImmunotherapeuticsFY2025— ——
Peer median (excluding OFIX) -64.8%-2.6 pp+46.2 pp

Competitors are the stored peer set for OFIX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue464.48M460.71M746.64M799.49M822.31M
Cost of Revenue114.91M123.54M260.37M253.61M270.61M
Gross Profit349.57M337.17M486.27M545.89M551.71M
Gross Margin75.3%73.2%65.1%68.3%67.1%
Research & Development49.62M49.07M80.23M73.64M57.11M
Selling, General & Admin290.67M308.78M530.4M532.53M456.39M
Operating Expenses357.88M350.44M625.38M630.5M620.18M
Depreciation & Amortization33.1M32.08M60.56M60.06M50.97M
EBITDA21.44M15.66M(79.49M)(34.18M)(22.35M)
EBITDA Margin4.6%3.4%-10.6%-4.3%-2.7%
Operating Income(8.32M)(13.27M)(139.11M)(84.62M)(68.47M)
Operating Margin-1.8%-2.9%-18.6%-10.6%-8.3%
Interest Income00000
Interest Expense1.84M1.29M8.63M29.63M17.49M
Other Income / Expenses(5.18M)(4.44M)(9.57M)(39.26M)(22.34M)
Income Before Tax(13.5M)(17.71M)(148.68M)(123.88M)(90.81M)
Pre-Tax Margin-2.9%-3.8%-19.9%-15.5%-11.0%
Income Tax Expense24.88M2.04M2.72M2.12M1.38M
Net Income(38.38M)(19.75M)(151.4M)(126M)(92.19M)
Net Margin-8.3%-4.3%-20.3%-15.8%-11.2%
EPS (Basic)(1.95)(0.98)(4.12)(3.30)(2.28)
EPS (Diluted)(1.95)(0.98)(4.12)(3.30)(2.28)
Weighted Avg Shares19.69M20.1M36.73M38.13M39.88M
Weighted Avg Shares (Diluted)19.69M20.1M36.73M38.13M39.88M

Orthofix Medical Inc.

NASDAQ:OFIX

Intrinsic Alpha fair value

Locked

Current Price

$6.61

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.